Dubai Telegraph - US drugmaker Eli Lilly says slashing insulin prices

EUR -
AED 3.8756
AFN 72.200575
ALL 98.139539
AMD 411.532283
ANG 1.916419
AOA 962.319203
ARS 1053.188708
AUD 1.630218
AWG 1.899315
AZN 1.784231
BAM 1.955003
BBD 2.146925
BDT 127.068214
BGN 1.956891
BHD 0.397718
BIF 3140.020304
BMD 1.055175
BND 1.421121
BOB 7.348005
BRL 6.129194
BSD 1.063362
BTN 89.676253
BWP 14.428257
BYN 3.479882
BYR 20681.429409
BZD 2.143327
CAD 1.478495
CDF 3023.076626
CHF 0.936043
CLF 0.037472
CLP 1033.976525
CNY 7.638303
CNH 7.648689
COP 4726.12869
CRC 542.978712
CUC 1.055175
CUP 27.962137
CVE 110.22008
CZK 25.288011
DJF 189.351934
DKK 7.458214
DOP 64.043899
DZD 141.622416
EGP 52.009895
ERN 15.827625
ETB 129.779309
FJD 2.40258
FKP 0.83167
GBP 0.831235
GEL 2.880458
GGP 0.83167
GHS 17.173001
GIP 0.83167
GMD 74.917819
GNF 9164.265159
GTQ 8.216651
GYD 222.469334
HKD 8.212268
HNL 26.846059
HRK 7.526869
HTG 139.81302
HUF 408.163026
IDR 16774.7496
ILS 3.959224
IMP 0.83167
INR 89.068533
IQD 1392.932319
IRR 44414.948032
ISK 147.313122
JEP 0.83167
JMD 168.341393
JOD 0.748221
JPY 164.500191
KES 136.329796
KGS 90.952195
KHR 4308.244201
KMF 492.080753
KPW 949.658078
KRW 1481.418127
KWD 0.324772
KYD 0.886139
KZT 524.106404
LAK 23352.482837
LBP 95221.093219
LKR 310.793338
LRD 200.438313
LSL 19.102015
LTL 3.115657
LVL 0.638265
LYD 5.151876
MAD 10.572991
MDL 19.161191
MGA 4961.977776
MKD 61.584316
MMK 3427.167142
MNT 3585.4848
MOP 8.519528
MRU 42.330748
MUR 50.047248
MVR 16.302766
MWK 1843.848551
MXN 21.712439
MYR 4.735102
MZN 67.423993
NAD 19.102015
NGN 1777.041223
NIO 39.134051
NOK 11.764987
NPR 143.481165
NZD 1.799094
OMR 0.406253
PAB 1.063367
PEN 4.030158
PGK 4.274258
PHP 62.064863
PKR 295.443194
PLN 4.34422
PYG 8298.578641
QAR 3.87682
RON 4.97705
RSD 116.980897
RUB 103.919035
RWF 1459.505187
SAR 3.964662
SBD 8.846117
SCR 14.382386
SDG 634.688134
SEK 11.596378
SGD 1.419896
SHP 0.83167
SLE 24.073878
SLL 22126.461188
SOS 607.652355
SRD 37.226828
STD 21839.991486
SVC 9.304208
SYP 2651.158922
SZL 19.108032
THB 36.972803
TJS 11.329783
TMT 3.703664
TND 3.346836
TOP 2.471323
TRY 36.237853
TTD 7.226055
TWD 34.365466
TZS 2801.489873
UAH 43.929697
UGX 3902.409597
USD 1.055175
UYU 44.831729
UZS 13603.455994
VES 47.479192
VND 26796.168359
VUV 125.272516
WST 2.950778
XAF 655.689778
XAG 0.035082
XAU 0.000412
XCD 2.851663
XDR 0.801074
XOF 655.686672
XPF 119.331742
YER 263.580476
ZAR 19.275884
ZMK 9497.834156
ZMW 29.087146
ZWL 339.76591
  • CMSD

    -0.0200

    24.73

    -0.08%

  • CMSC

    0.0700

    24.61

    +0.28%

  • RBGPF

    59.2500

    59.25

    +100%

  • SCS

    -0.3000

    13.37

    -2.24%

  • NGG

    -0.7800

    62.12

    -1.26%

  • BCE

    -0.4800

    27.21

    -1.76%

  • BCC

    1.4200

    142.55

    +1%

  • RIO

    -0.5800

    60.62

    -0.96%

  • RYCEF

    -0.0400

    7.07

    -0.57%

  • RELX

    -0.4700

    46.12

    -1.02%

  • VOD

    0.2800

    8.75

    +3.2%

  • JRI

    0.0200

    13.24

    +0.15%

  • AZN

    0.1000

    65.29

    +0.15%

  • GSK

    -0.4100

    35.11

    -1.17%

  • BP

    0.4100

    28.57

    +1.44%

  • BTI

    0.1800

    35.42

    +0.51%

US drugmaker Eli Lilly says slashing insulin prices
US drugmaker Eli Lilly says slashing insulin prices / Photo: FREDERICK FLORIN - AFP/File

US drugmaker Eli Lilly says slashing insulin prices

US pharmaceutical giant Eli Lilly announced Wednesday it would cut the cost of its insulin by 70 percent, with President Joe Biden calling on others to follow suit to tackle soaring drug prices.

Text size:

Manufacturers have ratcheted up insulin prices in recent years, hitting millions of Americans living with diabetes -- and drawing sharp political criticism.

"Insulin costs less than $10 to make, but Americans are sometimes forced to pay over $300 for it. It's flat wrong," said Biden, hailing Eli Lilly's price cut as "huge news."

"It's time for other manufacturers to follow," he added.

Indianapolis-based Lilly announced a series of steps to rein in prices of the life-saving drug, such as capping out-of-pocket costs at $35 per month for people with insurance.

"Lilly is taking these actions to make it easier to access Lilly insulin and help Americans who may have difficulty navigating a complex healthcare system," the drugmaker said in a statement.

While the $35 cap takes effect immediately, other measures will be implemented in the course of 2023.

A centerpiece is the 70 percent price drop in Humalog, Lilly's most commonly prescribed insulin.

The incidence of diabetes in the United States in adults has doubled over the last 20 years, afflicting 37.3 million people, according to the US Centers for Disease Control and Prevention.

Insulin prices have soared in the US, costing over eight times more than in 32 comparable high-income countries, a 2020 Rand Corporation study found.

The unaffordability of insulin -- particularly to uninsured Americans -- has become a rallying cry for pharmaceutical industry critics.

- Self-rationing insulin -

The cost of a five-pack of Humalog is currently $530.40, although the out-of-pocket price to a user varies depending on one's insurance plan. An average monthly use varies by user, Eli Lilly says on its website.

Drug pricing in the United States is affected not only by the cost of producing and distributing the pharmaceutical, but also other players such as insurers and pharmacy benefit management companies.

Critics such as progressive Senator Bernie Sanders have blasted the industry as emblematic of "unacceptable corporate greed."

"At a time when Eli Lilly made over $7 billion in profits last year, public pressure forced them to reduce the price of insulin by 70%," Sanders said Wednesday after the price-cut announcement.

"Sanofi and Novo Nordisk must do the same," he added, referring to two other companies which along with Lilly dominate the insulin market.

A survey by nonprofit T1International showed that one in four respondents living with diabetes reported rationing their insulin because of the financial strain.

The Inflation Reduction Act, signed into law last year by Biden, capped insulin prices for Medicare recipients at $35 per month, but people with private insurance or without insurance were left out.

Biden, in his State of the Union Address, called on lawmakers to rein in "Big Pharma" and "finish the job this time" by instituting a national cap on insulin.

In the company's statement, Eli Lilly Chief Executive David Ricks called on rival producers to join the effort.

"We know that 7 out of 10 Americans don't use Lilly insulin. We are calling on policymakers, employers and others to join us in making insulin more affordable," said Ricks.

"While the current healthcare system provides access to insulin for most people with diabetes, it still does not provide affordable insulin for everyone and that needs to change."

The company's statement referred uninsured consumers to an insulin affordability website, saying they could "receive Lilly insulins for $35 per month."

J.Alaqanone--DT